Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score A Study for the Neoadjuvant Treatment of Breast Cancer 06/15/2022 INTERVENTIONAL unchanged 1,533.85 0 A Study for the Adjuvant Treatment of Breast Cancer 06/15/2022 INTERVENTIONAL unchanged 1,533.85 0 Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations 06/16/2022 INTERVENTIONAL unchanged 1,532.85 0 Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr 06/16/2022 INTERVENTIONAL unchanged 1,532.85 0 Fetal Endoscopic Tracheal Occlusion for CDH (CDH) 06/16/2022 INTERVENTIONAL unchanged 1,532.85 0 Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies 06/21/2022 OBSERVATIONAL unchanged 1,527.85 0 Efficacy and Feasibility of an eHealth Intervention for Pregnant Women on Diet, Physical Activity and Knowledge Related to Pregnancy 06/21/2022 INTERVENTIONAL unchanged 1,527.85 0 A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane 06/21/2022 INTERVENTIONAL unchanged 1,527.85 0 Vitamin B12 Dose Escalation Trial in Pregnancy 06/22/2022 INTERVENTIONAL unchanged 1,526.85 0 Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy 06/22/2022 INTERVENTIONAL unchanged 1,526.85 0 A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients 06/22/2022 INTERVENTIONAL unchanged 1,526.85 0 Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management 06/22/2022 INTERVENTIONAL unchanged 1,526.85 0 A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) 06/24/2022 INTERVENTIONAL unchanged 1,524.85 0 Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer 06/24/2022 INTERVENTIONAL unchanged 1,524.85 0 Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer 06/24/2022 OBSERVATIONAL unchanged 1,524.85 0 Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test 06/24/2022 INTERVENTIONAL unchanged 1,524.85 0 ESAN II - Energy Sensing in Depression 06/27/2022 INTERVENTIONAL unchanged 1,521.85 0 Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women 06/27/2022 INTERVENTIONAL unchanged 1,521.85 0 Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment 06/27/2022 OBSERVATIONAL unchanged 1,521.85 0 Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters 06/27/2022 INTERVENTIONAL unchanged 1,521.85 0 The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study 06/27/2022 INTERVENTIONAL unchanged 1,521.85 0 Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive Pregnancies 06/27/2022 INTERVENTIONAL unchanged 1,521.85 0 Efficacy of High-intensity Exercise in Women With Prediabetes 06/28/2022 INTERVENTIONAL unchanged 1,520.85 0 Behavioral Intervention to Reduce Stress Among Black Gender Minority Women 06/28/2022 INTERVENTIONAL unchanged 1,520.85 0 Adverse Outcomes Following Female Genital Fistula Repair 06/29/2022 OBSERVATIONAL unchanged 1,519.85 0 Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans 06/30/2022 OBSERVATIONAL unchanged 1,518.85 0 Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study. 06/30/2022 INTERVENTIONAL unchanged 1,518.85 0 The Postoperative Radiotherapy in N1 Breast Cancer Patients 06/30/2022 INTERVENTIONAL unchanged 1,518.85 0 PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients 06/30/2022 INTERVENTIONAL unchanged 1,518.85 0 Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy 07/01/2022 OBSERVATIONAL unchanged 1,517.85 0 Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy 07/01/2022 INTERVENTIONAL unchanged 1,517.85 0 Lymphaticovenous Anastomosis as Treatment for Lymphedema 07/01/2022 INTERVENTIONAL unchanged 1,517.85 0 Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer 07/05/2022 INTERVENTIONAL unchanged 1,513.85 0 Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years 07/05/2022 INTERVENTIONAL unchanged 1,513.85 0 Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management 07/06/2022 INTERVENTIONAL unchanged 1,512.85 0 Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start 07/06/2022 INTERVENTIONAL unchanged 1,512.85 0 A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China 07/06/2022 OBSERVATIONAL unchanged 1,512.85 0 Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer 07/06/2022 INTERVENTIONAL unchanged 1,512.85 0 ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer 07/06/2022 INTERVENTIONAL unchanged 1,512.85 0 Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer 07/06/2022 OBSERVATIONAL unchanged 1,512.85 0 Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir 07/06/2022 INTERVENTIONAL unchanged 1,512.85 0 Effect of GH on the Blastocyst Euploid Rate in AMA Patients 07/07/2022 INTERVENTIONAL unchanged 1,511.85 0 Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) 07/07/2022 INTERVENTIONAL unchanged 1,511.85 0 Motiva Flora Tissue Expander PMCF 07/07/2022 INTERVENTIONAL unchanged 1,511.85 0 Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid 07/07/2022 INTERVENTIONAL unchanged 1,511.85 0 Biological Matrices Versus Synthetic Meshes 07/08/2022 INTERVENTIONAL unchanged 1,510.85 0 Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD) 07/08/2022 OBSERVATIONAL unchanged 1,510.85 0 Trial of FETO for Severe Congenital Diaphragmatic Hernia 07/11/2022 INTERVENTIONAL unchanged 1,507.85 0 V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) 07/11/2022 INTERVENTIONAL unchanged 1,507.85 0 Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding 07/11/2022 OBSERVATIONAL unchanged 1,507.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology